What Are Stents and Why Do We Use Them?
Share
When someone has a heart attack or blocked arteries, doctors often use a small device called a stent. A stent is a tiny mesh tube placed in the arteries to keep them open and ensure blood can flow properly to the heart. This is done through a procedure called angioplasty.
Stents are often coated with medicine that slowly releases over time to prevent the artery from getting blocked again. These are called drug-eluting stents (DES). Over the years, newer types of stents have been developed with different materials and coatings to improve patient outcomes.
The Problem: Neo-Atherosclerosis
Even with modern stents, a problem called neo-atherosclerosis can occur. This means new plaque builds up inside the stent over time, narrowing the artery again. It’s like your body forgetting that a stent is there to help, and treating it as something foreign. This can lead to late stent failure and increase the risk of another heart event.
To solve this, some companies developed biodegradable polymer stents—ones that dissolve over time—hoping this would reduce inflammation and lower the chances of neo-atherosclerosis compared to older durable polymer stents.
What Did the CONNECT Trial Study?
A major study, called the CONNECT trial, looked at patients who had suffered a specific type of heart attack called STEMI. Researchers compared two types of modern everolimus-eluting stents: one with a biodegradable polymer and the other with a durable one.
They used a special imaging tool called OCT to check inside the arteries three years after the stents were implanted. The goal was to see if the biodegradable stent led to less neo-atherosclerosis.
Surprisingly, both types of stents had very similar results. The biodegradable stent had a rate of 11.4% for neo-atherosclerosis, while the durable one had 13.3%. This small difference was not significant. The study also had fewer cases of neo-atherosclerosis than expected overall.
The Real Game-Changer: Statins
One major reason for the low rates of artery re-narrowing? Statins—medications that lower cholesterol and reduce inflammation in blood vessels.
In the trial, patients who were taking high-intensity statins had a much lower rate of neo-atherosclerosis—just 8.5%, compared to 27.8% in those who were not on high-intensity statins. This benefit happened regardless of which type of stent was used.
This tells us that statins had a much stronger impact on artery health than the small differences between stent types.
Key Takeaways for Patients
-
Stent type matters—but not as much as we thought: While newer stents are carefully designed, their differences don’t seem to affect long-term outcomes as much as previously believed.
-
Statins are powerful tools: If you’ve had a stent placed, taking your prescribed statin—especially a high-intensity one—can greatly reduce your risk of complications.
-
Medical therapy is crucial: The way your body reacts over time has more to do with your ongoing care (like medications and lifestyle changes) than with the type of stent itself.
Final Thoughts
This study is a great reminder that while technology in heart care keeps improving, basic treatments like statins remain incredibly important. If you’ve had a stent, don’t just rely on the procedure alone—stick with your medications, follow your doctor’s advice, and take care of your overall heart health.
In the end, statins are winning the race against in-stent artery disease—not because they’re flashy or new, but because they work.